Comprehensive-Care for Multimorbid Adults Effectiveness Study

Overview

This study is intended to examine whether directed care of a nurse working jointly with the patient's primary care physician, including a comprehensive assessment, creation of a tailored care plan, proactive follow-up, self management support and caregiver support and care coordination, can reduce hospital admissions for patients with multiple chronic conditions.

Full Title of Study: “The Clalit Comprehensive-Care for Multimorbid Adults Project”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Non-Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Health Services Research
    • Masking: None (Open Label)
  • Study Primary Completion Date: March 2017

Detailed Description

Patients with multi-morbidities pose a significant challenge for healthcare organizations because they require continuity of care among a wide range of long-term therapeutic paradigms for many different types of diseases. The current study is based on a treatment model entailing a nurse-primary care physician team to provide care for patients with multiple morbidities. Patients in the intervention group who agreed and signed the consent form to participate in the study will receive treatment by the physician – nurse team in accordance with the components of the Clalit's Comprehensive Care for Mutlimorbid Adults Project model. Components of the intervention include: 1. Comprehensive assessment of the patient's and family's needs 2. Coordinated care plan based on integrated care guides 3. "Multimorbid Action Plan" for patients 4. All-inclussive patient centered care and caregiver support 5. Proactive monitoring according to the plan. Patients in the control groups will receive usual care in their primary care clinics. The Usual Care Survey control group will complete study questionnaires at 6, 12 and 24 months after enrollement. The Usual Care Blinded group will be assessed only retrospectively based on deidentified information from Clalit's admistrative databases.

Interventions

  • Other: Nurse-physician comprehensive care
    • Components of the intervention include: Complete assessment of the patient’s and family’s needs conducted by the nurse. Comprehensive treatment program developed by the nurse and in consultation with the primary care physician. “Multimorbid care plan” integrating all care aspects. “Action Plan” for patients, supporting self management Proactive monitoring according to the plan.

Arms, Groups and Cohorts

  • Experimental: Nurse-physician comprehensive care
    • Comprehensive self management support and care coordination by a nurse-primary care physician team
  • No Intervention: Usual care survey control group
    • Patients will receive usual primary care and asked to complete questionnaires on four time points throughout the study
  • No Intervention: Usual care blinded control group
    • Patients will receive usual primary care.

Clinical Trial Outcome Measures

Primary Measures

  • Percent change in admissions for ambulatory care sensetive conditions
    • Time Frame: At enrollment and within 12 months and 24 months after enrollment
    • Ambulatory Care Sensitive Conditions will be defined by ICD-9 codes, based on the classification published by: Ansari, Barbetti, Carson, Auckland, & Cicuttini, 2003 (adapted from Weissman JS, Gatsonis C, Epstein AM ,1992; Millman M, ed. 1993)

Secondary Measures

  • Emergency 30-day readmissions
    • Time Frame: 30 days post an index admission
    • Emergency readmissions are defined as an urgent (via the Emergency Room) admission of one night or longer, following an index admission that lasted 2 nights or longer, in the prior 30 days.

Participating in This Clinical Trial

Inclusion Criteria

  • ACG system high risk probabilty score – 4% Highest Risk Score – Age 18 and older – 2 or more chronic conditions Exclusion Criteria:

  • Patients already included in a controlled disease management program (e.g., COPD disease management and telehealth). – Participation in any medical research. – Confined to bed. – Inpatient nursing care, nursing homes. – Kidney, liver or heart transplant patients. – Active (receipt of oncology chemotherapy , radiotherapy or other oncology treatment during the past 3 years). – Dialysis patients. – Clalit Healthcare Services employees. – Patients with major active mental illness, such as schizophrenia. – Cognitive failure. – Non Hebrew speaking patients without Hebrew speaking primary informal caregiver. – Bedridden patients – Housebound patients

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 95 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Meir Medical Center
  • Collaborator
    • Israel National Institute for Health Policy and Health Services Research
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Ran D Balicer, PhD, Principal Investigator, Clalit Research Institute, Clalit Health Services

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.